 |
|
Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies
Verdiana Ravarotto, Giovanni Bertoldi, Lucia Federica Stefanelli, Federico Nalesso, Lorenzo A. Calò
Kidney Res Clin Pract. 2022;41(5):533-544. Published online 2022 Sep 30 DOI: https://doi.org/10.23876/j.krcp.22.069
|
|
Citations to this article as recorded by
 Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
Giovanni Bertoldi, Ilaria Caputo, Giulia Driussi, Lucia Federica Stefanelli, Valentina Di Vico, Gianni Carraro, Federico Nalesso, Lorenzo A. Calò
Journal of Clinical Medicine.2023; 12(5): 2063. CrossRef Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes
Luca Sgarabotto, Verdiana Ravarotto, Lucia Federica Stefanelli, Martina Cacciapuoti, Paul A. Davis, Federico Nalesso, Lorenzo A. Calò
Antioxidants.2023; 12(4): 811. CrossRef Sarcopenia in chronic kidney disease: from bench to bedside
Da Woon Kim, Sang Heon Song
The Korean Journal of Internal Medicine.2023; 38(3): 303. CrossRef Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis
Chan Ho Kim, Hye-Young Kang, Gyuri Kim, Jimin Park, Bo Young Nam, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Tae-Hyun Yoo
Frontiers in Pharmacology.2023;[Epub] CrossRef Understanding and Treatment Strategies of Hypertension and Hyperkalemia in Chronic Kidney Disease
Sang Min Jo
Electrolytes & Blood Pressure.2023; 21(1): 24. CrossRef The RAAS Goodfellas in Cardiovascular System
Ilaria Caputo, Giovanni Bertoldi, Giulia Driussi, Martina Cacciapuoti, Lorenzo A. Calò
Journal of Clinical Medicine.2023; 12(21): 6873. CrossRef
|